DENTSPLY SIRONA Inc. Files 8-K: Officer/Director Changes & More

Ticker: XRAY · Form: 8-K · Filed: Feb 6, 2025 · CIK: 818479

Dentsply Sirona Inc. 8-K Filing Summary
FieldDetail
CompanyDentsply Sirona Inc. (XRAY)
Form Type8-K
Filed DateFeb 6, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: officer-departure, director-election, executive-compensation, financial-reporting

Related Tickers: XRAY

TL;DR

DENTSPLY SIRONA filed an 8-K detailing leadership changes and financial updates.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on February 6, 2025, reporting events as of February 5, 2025. The filing includes updates on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. It also covers Regulation FD disclosures and financial statements/exhibits.

Why It Matters

This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: medium — Changes in directors or officers, especially if unexpected, can indicate underlying issues or strategic realignments that may affect the company's future performance.

Key Players & Entities

  • DENTSPLY SIRONA Inc. (company) — Registrant
  • February 5, 2025 (date) — Date of earliest event reported
  • February 6, 2025 (date) — Date of report

FAQ

What specific officer or director positions were affected by the changes reported in this 8-K?

The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and positions are not detailed in the provided excerpt.

Are there any new compensatory arrangements for officers mentioned in the filing?

Yes, the filing explicitly lists 'Compensatory Arrangements of Certain Officers' as an item of information, suggesting new or updated compensation details.

Does this 8-K filing include any financial statements?

Yes, the filing lists 'Financial Statements and Exhibits' as an item of information.

What is the primary purpose of a Regulation FD Disclosure?

Regulation FD (Fair Disclosure) aims to prevent selective disclosure of material nonpublic information by requiring companies to make such disclosures publicly.

What is DENTSPLY SIRONA Inc.'s Standard Industrial Classification code?

DENTSPLY SIRONA Inc.'s Standard Industrial Classification code is 3843, which corresponds to DENTAL EQUIPMENT & SUPPLIES.

Filing Stats: 742 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-02-06 08:32:24

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure The Company's press release announcing the appointment of Messrs. Barber and Scavilla as members of the Board and the resignation of Dr. Wenzel as a member of the Board is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits (d) Exhibits: 99.1 DENTSPLY SIRONA Inc. Press Release Issued February 6, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. By: /s/ Richard C. Rosenzweig Richard C. Rosenzweig Executive Vice President, Corporate Development, General Counsel and Secretary Date: February 6, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.